SUBSCRIBE
SUBSCRIBE
News   Deals

GlaxoSmithKline Gets US Okay to Buy Heart Drug Maker Reliant Pharmaceuticals, Inc.

December 17, 2007 | 
1 min read
WASHINGTON, Dec 14 (Reuters) - U.S. antitrust authorities have cleared GlaxoSmithKline Plc (GSK.L: Quote, Profile, Research) to buy privately held heart drug specialist Reliant Pharmaceuticals.
Mergers & acquisitions
GlaxoSmithKline
MORE ON THIS TOPIC
Contemporary art collage. Hand put money to golden stack of coins, meaning income from investment. Concept of business strategy, investment, development, market, finance.
Mergers & acquisitions
SpringWorks Surges on Potential $3.5B Merck KGaA Buyout
April 25, 2025
 · 
2 min read
 · 
Tristan Manalac
Roche's tower in Shanghai, China
Tariffs
Roche in ‘Very, Very Good Position’ To Weather Trump Tariffs but M&A May Suffer
April 24, 2025
 · 
2 min read
 · 
Tristan Manalac
New York City, New York United States - August 29 2021: NASDAQ, National Association of Securities Dealers Automated Quotations corporate logo sign near Times Square.
IPO
Swiss ADC Biotech Takes SPAC Track to NASDAQ
April 23, 2025
 · 
1 min read
 · 
Annalee Armstrong
Creative sketch collage of business people handshake gesture approval project development success colleagues cooperation support.
Deals
Genentech Offers up to $765M in Biobucks to Repertoire for I&I Drug Discovery
April 23, 2025
 · 
1 min read
 · 
Dan Samorodnitsky